Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Valeant Sheds Staff, Creates Executive Panel After Bausch & Lomb Deal

This article was originally published in The Tan Sheet

Executive Summary

The fast-growing, Canadian specialty pharma will shed more than 2,700 jobs as it absorbs Bausch & Lomb, as part of an endeavor to save $800 million. CEO Mike Pearson’s note to employees describes a new organizational philosophy, with restructured management and business units.

Advertisement

Related Content

Actavis’ Brent Saunders And Paul Bisaro Talk Innovation Vs. Discovery
Valeant Keeps Door Open For Consumer Products Acquisitions
Valeant Keeps Door Open For Consumer Products Acquisitions
Bausch + Lomb Buy Vaults Valeant Into Consumer Eye Care Space
Valeant Continues Buying Spree With $2.6B Acquisition Of Medicis
Tax Benefits Highlight Announced Merger Of Valeant And Biovail

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel